Zivo Bioscience Inc. Warrants Cash Flow-to-Debt Ratio
Zivo Bioscience Inc. Warrants cash flow-to-debt ratio. Zivo Bioscience Inc. Warrants (ZIVOW) has a Cash Flow-to-Debt Ratio of -1.15x as of September 2025, meaning its operating cash flow of $-266.56K could theoretically repay -1% of its total liabilities ($231.79K) in one year. Check Zivo Bioscience Inc. Warrants (ZIVOW) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zivo Bioscience Inc. Warrants (2003–2024)
Cash flow-to-debt ratio of Zivo Bioscience Inc. Warrants from 2003 to 2024. Historical debt coverage capacity for Zivo Bioscience Inc. Warrants across 22 annual periods. Check Zivo Bioscience Inc. Warrants (ZIVOW) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Zivo Bioscience Inc. Warrants Cash Flow-to-Debt Ratio by Year (2003–2024)
Zivo Bioscience Inc. Warrants cash flow-to-debt ratio by year from 2003 to 2024. Year-by-year debt coverage analysis for Zivo Bioscience Inc. Warrants. For the full cash flow conversion analysis, see ZIVOW operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.00x | $-4.31 Million | $2.16 Million | ▲ +4.8% |
| 2023 | -2.10x | $-5.80 Million | $2.76 Million | ▲ +36.9% |
| 2022 | -3.33x | $-7.10 Million | $2.13 Million | ▼ -44.2% |
| 2021 | -2.31x | $-6.80 Million | $2.95 Million | ▼ -928.1% |
| 2020 | -0.22x | $-2.59 Million | $11.53 Million | ▲ +47.3% |
| 2019 | -0.43x | $-3.71 Million | $8.71 Million | ▼ -93.0% |
| 2018 | -0.22x | $-5.01 Million | $22.69 Million | ▼ -6.7% |
| 2017 | -0.21x | $-4.24 Million | $20.51 Million | ▼ -16.8% |
| 2016 | -0.18x | $-2.54 Million | $14.36 Million | ▲ +26.2% |
| 2015 | -0.24x | $-2.30 Million | $9.57 Million | ▲ +43.2% |
| 2014 | -0.42x | $-2.74 Million | $6.47 Million | ▼ -66.6% |
| 2013 | -0.25x | $-2.99 Million | $11.77 Million | ▲ +40.0% |
| 2012 | -0.42x | $-1.77 Million | $4.19 Million | ▲ +18.4% |
| 2011 | -0.52x | $-1.29 Million | $2.49 Million | ▲ +53.5% |
| 2010 | -1.11x | $-1.44 Million | $1.29 Million | ▼ -305.8% |
| 2009 | -0.27x | $-1.15 Million | $4.19 Million | ▲ +72.0% |
| 2008 | -0.98x | $-935.82K | $954.74K | ▲ +28.2% |
| 2007 | -1.37x | $-1.41 Million | $1.03 Million | ▲ +24.5% |
| 2006 | -1.81x | $-2.09 Million | $1.15 Million | ▼ -37.1% |
| 2005 | -1.32x | $-1.65 Million | $1.25 Million | ▼ -19.1% |
| 2004 | -1.11x | $-1.28 Million | $1.16 Million | ▼ -191.6% |
| 2003 | -0.38x | $-17.39K | $45.78K | — |